WeChat Mini Program
Old Version Features

Using Non-Inferiority Test of Proportions in Design of Randomized Non-Inferiority Trials with Time-to-event Endpoint with a Focus on Low-Event-rate Setting

Clinical Trials(2024)SCI 3区

Cited 0|Views1
Abstract
Background/aims For cancers with low incidence, low event rates, and a time-to-event endpoint, a randomized non-inferiority trial designed based on the logrank test can require a large sample size with significantly prolonged enrollment duration, making such a non-inferiority trial not feasible. This article evaluates a design based on a non-inferiority test of proportions, compares its required sample size to the non-inferiority logrank test, assesses whether there are scenarios for which a non-inferiority test of proportions can be more efficient, and provides guidelines in usage of a non-inferiority test of proportions. Methods This article describes the sample size calculation for a randomized non-inferiority trial based on a non-inferiority logrank test or a non-inferiority test of proportions. The sample size required by the two design methods are compared for a wide range of scenarios, varying the underlying Weibull survival functions, the non-inferiority margin, and loss to follow-up rate. Results Our results showed that there are scenarios for which the non-inferiority test of proportions can have significantly reduced sample size. Specifically, the non-inferiority test of proportions can be considered for cancers with more than 80% long-term survival rate. We provide guidance in choice of this design approach based on parameters of the Weibull survival functions, the non-inferiority margin, and loss to follow-up rate. Conclusion For cancers with low incidence and low event rates, a non-inferiority trial based on the logrank test is not feasible due to its large required sample size and prolonged enrollment duration. The use of a non-inferiority test of proportions can make a randomized non-inferiority Phase III trial feasible.
More
Translated text
Key words
Phase III,non-inferiority design,logrank test,test of proportions,time-to-event endpoint,sample size
求助PDF
上传PDF
Bibtex
AI Read Science
AI Summary
AI Summary is the key point extracted automatically understanding the full text of the paper, including the background, methods, results, conclusions, icons and other key content, so that you can get the outline of the paper at a glance.
Example
Background
Key content
Introduction
Methods
Results
Related work
Fund
Key content
  • Pretraining has recently greatly promoted the development of natural language processing (NLP)
  • We show that M6 outperforms the baselines in multimodal downstream tasks, and the large M6 with 10 parameters can reach a better performance
  • We propose a method called M6 that is able to process information of multiple modalities and perform both single-modal and cross-modal understanding and generation
  • The model is scaled to large model with 10 billion parameters with sophisticated deployment, and the 10 -parameter M6-large is the largest pretrained model in Chinese
  • Experimental results show that our proposed M6 outperforms the baseline in a number of downstream tasks concerning both single modality and multiple modalities We will continue the pretraining of extremely large models by increasing data to explore the limit of its performance
Upload PDF to Generate Summary
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Related Papers
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
Chat Paper

要点】:本文针对低发生率癌症,提出了一种基于比例的非劣效性检验设计方法,以减少所需样本量和缩短招募时间,并与传统的基于对数秩检验的非劣效性试验设计进行了比较。

方法】:文章详细描述了基于非劣效性对数秩检验和比例的非劣效性检验的随机非劣效性试验样本量计算方法,并通过改变Weibull生存函数、非劣效性边界和失访率等多种场景进行了样本量的比较。

实验】:研究结果表明,在特定场景下,比例的非劣效性检验可以显著减少所需的样本量。特别是对于长期生存率超过80%的癌症,可以考虑使用比例的非劣效性检验设计方法。文中还提供了基于Weibull生存函数参数、非劣效性边界和失访率选择此设计方法的指导。数据集名称在文中未明确提及。